Cargando…

FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma

BACKGROUND: Previous studies have elucidated that FOXM1 may predict poor prognosis in patients with multiple solid malignant tumors. In this study we explored the differential expression of FOXM1 in stage IIA esophageal squamous cell carcinoma (ESCC) and investigated its prognostic value. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Zhaohua, Jia, Yang, Jiang, Wenpeng, Wang, Zhou, Zhang, Zhiping, Gao, Yanyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068428/ https://www.ncbi.nlm.nih.gov/pubmed/29877046 http://dx.doi.org/10.1111/1759-7714.12776

Ejemplares similares

Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy
por: Jia, Yang, et al.
Publicado: (2017)

Overexpression of IFITM3 predicts the high risk of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy
por: Jia, Yang, et al.
Publicado: (2015)

A prognostic model for stratification of stage IB/IIA esophageal squamous cell carcinoma: a retrospective study
por: Wu, Lei-Lei, et al.
Publicado: (2021)

Cytoplasmic Forkhead Box M1 (FoxM1) in Esophageal Squamous Cell Carcinoma Significantly Correlates with Pathological Disease Stage
por: Hui, Marco K. C., et al.
Publicado: (2011)

CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway
por: Jia, Yang, et al.
Publicado: (2018)

Clinical impact of remnant lymphatic invasion on the recurrence of esophageal squamous cell carcinoma after esophagectomy with neoadjuvant chemotherapy
por: Okuda, Sho, et al.
Publicado: (2022)

Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1
por: Yu, Jiao, et al.
Publicado: (2017)

FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma
por: Jia, Rong, et al.
Publicado: (2023)

Clinical analysis of 312 patients with stage IB1-IIA2 cervical squamous cell carcinoma and research on the influencing factors of postoperative recurrence
por: Zeng, Jia, et al.
Publicado: (2023)

RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial-mesenchymal transition through TGF-β/Smad signaling
por: Xiao, Zhaohua, et al.
Publicado: (2020)

The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa–IVa lower thoracic oesophageal squamous cell carcinoma
por: Wang, Yichun, et al.
Publicado: (2018)

CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma
por: Jiang, Wenpeng, et al.
Publicado: (2017)

Postoperative lymphatic recurrence distribution and delineation of the radiation field in lower thoracic squamous cell esophageal carcinomas: a real-world study
por: Du, Rongxu, et al.
Publicado: (2022)

Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma
por: Tanabe, Kan, et al.
Publicado: (2016)

Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma
por: Yun, Tak, et al.
Publicado: (2011)

Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
por: Kim, Hyo Song, et al.
Publicado: (2015)

The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma
por: Song, Yan, et al.
Publicado: (2021)

Immunotherapy with or without radiotherapy for metastatic or recurrent esophageal squamous cell carcinoma: A real-world study
por: Wu, Xiaoyue, et al.
Publicado: (2022)

LncRNA GACAT3 promotes esophageal squamous cell carcinoma progression through regulation of miR-149/FOXM1
por: Su, Min, et al.
Publicado: (2021)

FoxM1 knockdown enhanced radiosensitivity of esophageal cancer by inducing apoptosis
por: Qin, Qin, et al.
Publicado: (2023)

Recurrent Syncope due to Esophageal Squamous Cell Carcinoma
por: Casini, A., et al.
Publicado: (2011)

FOXM1 is a novel predictor of recurrence in patients with oral squamous cell carcinoma associated with an increase in epithelial-mesenchymal transition
por: Luo, Ya-Dong, et al.
Publicado: (2019)

The prognostic role of nutrition risk score (NRS) in patients with metastatic or recurrent esophageal squamous cell carcinoma (ESCC)
por: Zhou, Xia, et al.
Publicado: (2017)

Maternal Embryonic Leucine Zipper Kinase Promotes Tumor Growth and Metastasis via Stimulating FOXM1 Signaling in Esophageal Squamous Cell Carcinoma
por: Chen, Liang, et al.
Publicado: (2020)

Low-density lipoprotein promotes lymphatic metastasis of esophageal squamous cell carcinoma and is an adverse prognostic factor
por: Deng, Hongbin, et al.
Publicado: (2019)

Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma
por: Liu, Tong, et al.
Publicado: (2021)

Metastatic squamous cell carcinoma of colon from esophageal cancer
por: Garg, Natasha, et al.
Publicado: (2017)

Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

Zosteriform skin metastasis caused by retrograde lymphatic migration of metastatic squamous cell lung carcinoma
por: Maki, Yohei, et al.
Publicado: (2021)

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
por: Klinhom-on, Nathakan, et al.
Publicado: (2021)

Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma
por: Masuda, Ryota, et al.
Publicado: (2017)

Predictive value of nutritional indicators with regard to the survival outcomes in patients with metastatic esophageal squamous cell carcinoma treated with camrelizumab
por: Liu, Jiang, et al.
Publicado: (2023)

The role of vascular invasion and lymphatic invasion in predicting recurrent thoracic oesophageal squamous cell carcinoma
por: Ma, Yu, et al.
Publicado: (2022)

Irinotecan plus fluorouracil‐based regimen as second or third‐line chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma
por: Wang, Xi, et al.
Publicado: (2015)

Genetic polymorphisms of ATG5 predict survival and recurrence in patients with early-stage esophageal squamous cell carcinoma
por: Yang, Pei-Wen, et al.
Publicado: (2017)

Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma
por: Xiao, Zhaohua, et al.
Publicado: (2023)

The Molecular Mechanisms of Tanshinone IIA on the Apoptosis and Arrest of Human Esophageal Carcinoma Cells
por: Wang, Jiang-Feng, et al.
Publicado: (2014)

Machine learning to predict occult metastatic lymph nodes along the recurrent laryngeal nerves in thoracic esophageal squamous cell carcinoma
por: Zhang, Yiliang, et al.
Publicado: (2023)

The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

Fc fragment of immunoglobulin G receptor IIa (FCGR2A) as a new potential prognostic biomarker of esophageal squamous cell carcinoma
por: Lu, Sifen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lr64vjk4kr8sjjpsbf5ka3jggg